Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects

The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes

NCT04799327 ·Status: UNKNOWN ·Phase: PHASE2

Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

NCT00479492 ·Status: COMPLETED ·Phase: PHASE2

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

NCT03548987 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

NCT00796367 ·Status: COMPLETED ·Phase: PHASE3

A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses

NCT07280936 ·Status: RECRUITING ·Phase: PHASE1

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)

NCT05890976 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients

NCT00239174 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

NCT00500370 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

NCT00109148 ·Status: COMPLETED ·Phase: PHASE2

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)

NCT05035095 ·Status: COMPLETED ·Phase: PHASE3

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

NCT05564117 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

NCT05677867 ·Status: COMPLETED ·Phase: PHASE1

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

NCT02453711 ·Status: COMPLETED ·Phase: PHASE2

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

NCT07281937 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

NCT03095807 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT07081958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity

NCT05236517 ·Status: COMPLETED ·Phase: PHASE1

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

NCT06525935 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects

NCT01666691 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

NCT06445075 ·Status: COMPLETED ·Phase: PHASE2

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

NCT06662539 ·Status: COMPLETED ·Phase: PHASE2

A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese

NCT03707990 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

NCT01372761 ·Status: COMPLETED ·Phase: PHASE1

A Study of TG103 Injection in Overweight or Obesity

NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2